\-\ Texto\\:\\ \ \(0\)\
\-\ fever\\.\\ \\ no\\ focal\\ deficit\\.\ \(0\)\
\-\ antibiotics\\ with\\ almost\\ full\\ resolution\\ of\\ lesions\\ after\\ two\\ months\\.\ \(0\)\
\-\ \\â\\€\\¢\\ multiple\\ ring\\ enhancing\\ lesions\\ involving\\ both\\ cerebral\\ hemispheres\\.\\ \\ \ \(0\)\
\-\ \\â\\€\\¢\\ most\\ of\\ the\\ lesion\\ also\\ have\\ restricted\\ diffusion\\.\ \(0\)\
\-\ brain\\ abscess\\ \\(gram\\ positive\\ cocci\\)\\ with\\ streptococcus\ \(0\)\
\-\ \\â\\€\\¢\\ metastatic\\ disease\ \(13\)\
\-\ \\â\\€\\¢\\ bacterial\\ abscess\ \(0\)\
\-\ \\â\\€\\¢\\ toxoplasmosis\ \(0\)\
\-\ \\â\\€\\¢\\ multifocal\\ gbm\ \(0\)\
\-\ 21\\ year\\ old\\ adult\\ with\\ down\\ syndrome\\,\\ was\\ treated\\ for\\ otitis\\ media\\ 1\\ week\\ prior\\ to\\ admission\\.\\ \\ he\\ developed\\ severe\\ headache\\ and\\ fever\\ on\\ the\\ day\\ of\\ admission\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ admission\\:\\ 0\\.27090922091275527\ \(0\)\
\-\ fever\\:\\ 0\\.22014802285617924\ \(0\)\
\-\ abscess\\:\\ 0\\.20849650144262008\ \(0\)\
\-\ cocci\\:\\ 0\\.20635768637471055\ \(0\)\
\-\ streptococcus\\:\\ 0\\.19011980129722086\ \(0\)\
\-\ lesions\\:\\ 0\\.18647657189864647\ \(0\)\
\-\ otitis\\:\\ 0\\.18555639933802381\ \(0\)\
\-\ toxoplasmosis\\:\\ 0\\.18255780611688457\ \(0\)\
\-\ media\\:\\ 0\\.18072101962455214\ \(0\)\
\-\ gram\\:\\ 0\\.17298170105006216\ \(0\)\
\-\ gbm\\:\\ 0\\.17165772685860026\ \(0\)\
\-\ hemispheres\\:\\ 0\\.15764169209866563\ \(0\)\
\-\ multifocal\\:\\ 0\\.15764169209866563\ \(0\)\
\-\ deficit\\:\\ 0\\.15359536169097457\ \(0\)\
\-\ bacterial\\:\\ 0\\.15193054135744954\ \(0\)\
\-\ adult\\:\\ 0\\.14975218682898572\ \(0\)\
\-\ almost\\:\\ 0\\.1458397194494508\ \(0\)\
\-\ restricted\\:\\ 0\\.13954125292844757\ \(0\)\
\-\ ring\\:\\ 0\\.13675269986870806\ \(0\)\
\-\ diffusion\\:\\ 0\\.13675269986870806\ \(0\)\
\-\ down\\:\\ 0\\.13188176698047768\ \(0\)\
\-\ resolution\\:\\ 0\\.1317223250357753\ \(0\)\
\-\ 21\\:\\ 0\\.12972698485930745\ \(0\)\
\-\ full\\:\\ 0\\.12690682678500054\ \(0\)\
\-\ developed\\:\\ 0\\.12044889626101261\ \(0\)\
\-\ antibiotics\\:\\ 0\\.11960556603547348\ \(0\)\
\-\ involving\\:\\ 0\\.11371556703208219\ \(0\)\
\-\ cerebral\\:\\ 0\\.11247617035514809\ \(0\)\
\-\ headache\\:\\ 0\\.11191575227898502\ \(0\)\
\-\ week\\:\\ 0\\.10919598870425688\ \(0\)\
\-\ positive\\:\\ 0\\.10697898019860308\ \(0\)\
\-\ day\\:\\ 0\\.10341287758919619\ \(0\)\
\-\ severe\\:\\ 0\\.10277329308453724\ \(0\)\
\-\ enhancing\\:\\ 0\\.10170132109464129\ \(0\)\
\-\ brain\\:\\ 0\\.1012073013344168\ \(0\)\
\-\ treated\\:\\ 0\\.10109867405485992\ \(0\)\
\-\ syndrome\\:\\ 0\\.09787330423391258\ \(0\)\
\-\ focal\\:\\ 0\\.09710922310292996\ \(0\)\
\-\ two\\:\\ 0\\.09641106104485075\ \(0\)\
\-\ he\\:\\ 0\\.09613652213759981\ \(0\)\
\-\ with\\:\\ 0\\.09536929179561074\ \(0\)\
\-\ of\\:\\ 0\\.09531234269356302\ \(0\)\
\-\ months\\:\\ 0\\.09449965838292276\ \(0\)\
\-\ prior\\:\\ 0\\.09083397944692262\ \(0\)\
\-\ both\\:\\ 0\\.09053320716078153\ \(0\)\
\-\ metastatic\\:\\ 0\\.08903974513698991\ \(0\)\
\-\ most\\:\\ 0\\.08449080438509872\ \(0\)\
\-\ have\\:\\ 0\\.08110172053682403\ \(0\)\
\-\ multiple\\:\\ 0\\.07940792985758834\ \(0\)\
\-\ after\\:\\ 0\\.07875766595553203\ \(0\)\
\-\ lesion\\:\\ 0\\.07783323265119653\ \(0\)\
\-\ also\\:\\ 0\\.07636383652652895\ \(0\)\
\-\ disease\\:\\ 0\\.06814791411468116\ \(0\)\
\-\ the\\:\\ 0\\.06478860885923754\ \(0\)\
\-\ was\\:\\ 0\\.05657987799100591\ \(0\)\
\-\ no\\:\\ 0\\.0527937154473337\ \(0\)\
\-\ year\\:\\ 0\\.05003245075961691\ \(0\)\
\-\ for\\:\\ 0\\.04920642645669759\ \(0\)\
\-\ on\\:\\ 0\\.04903187630702335\ \(0\)\
\-\ old\\:\\ 0\\.04804847189186497\ \(0\)\
\-\ to\\:\\ 0\\.040586675841978406\ \(0\)\
\-\ and\\:\\ 0\\.03354722223489828\ \(0\)\
